Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Sex hormone-binding globulin (SHBG) is a serum protein released mainly by the liver, and a low serum level correlates with a risk for metabolic syndrome including diabetes, obesity, and cardiovascular events. However, the underlying molecular mechanism(s) linking SHBG and metabolic syndrome remains unknown. In this study, using adipocytes and macrophages, we focused on the in vitro effects of SHBG on inflammation as well as lipid metabolism. Incubation with 20 nM SHBG markedly suppressed lipopolysaccharide- (LPS-) induced inflammatory cytokines, such as MCP-1, TNF α , and IL-6 in adipocytes and macrophages, along with phosphorylations of JNK and ERK. Anti-inflammatory effects were also observed in 3T3-L1 adipocytes cocultured with LPS-stimulated macrophages. In addition, SHBG treatment for 18 hrs or longer significantly induced the lipid degradation of differentiated 3T3-L1 cells, with alterations in its corresponding gene and protein levels. Notably, these effects of SHBG were not altered by coaddition of large amounts of testosterone or estradiol. In conclusion, SHBG suppresses inflammation and lipid accumulation in macrophages and adipocytes, which might be among the mechanisms underlying the protective effect of SHBG, that is, its actions which reduce the incidence of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings lend support to the hypothesis that the increase in SHBG levels induced by liraglutide might contribute per se to reduce the risk of developing the metabolic syndrome in PCOS, also considering the effect of SHBG in directly suppressing inflammation and lipid accumulation in macrophages and adipocytes [65].”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 272 · cited 1×
“Pepck CTAACTTGGCCATGATGAACC CTTCACTGAGGTGCCAGGAG [31]”
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Acrp30 GCTCCTGCTTTGGTCCCTCCAC GCCCTTCAGCTCCTGTCATTCC [32]”
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889 · cited 1×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · cited 1×
“MCP-1, which is known to be highly expressed in adipocytes, is related to the induction of chronic inflammation [42].”
BackgroundThe family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667 · cited 2×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundNile red: a selective fluorescent stain for intracellular lipid droplets.
Greenspan, P., Mayer, E. P., & Fowler, S. D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.3.965 · Cited by 2,543 · cited 1×
“Nile Red (AdipoRed, Lonza) becomes fluorescent when it is partitioned in a hydrophobic environment and shows selective fluorescence for intracellular lipid droplets [41].”
BackgroundKawai, T., & Akira, S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,810 · cited 2×
“AP-1 regulates MCP-1, a key chemokine for monocyte/macrophage migration and infiltration [51].”
BackgroundThe Isolation and Characterization of Murine Macrophages
Zhang, X., Goncalves, R., & Mosser, D. M. (2008) · Current Protocols in Immunology · doi:10.1002/0471142735.im1401s83 · Cited by 1,536
Research works printed but not linked: 2
- 2003, Medical Science Monitor, 9, Cr152
- 2005, Clinical Laboratory, 51, 625
Cited by
Qu, X., & Donnelly, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218191 · Cited by 210
“of metabolic syndrome and its complications [64].”
BackgroundMale Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
Fernandez, C. J., Department of Endocrinology & Metabolism, P. H., Chacko, E. C., Department of Endocrinology, J. G. H., Pappachan, J. M., & Department of Endocrinology & Metabolism, L. T. H. N. F. T. (2019) · European Endocrinology · doi:10.17925/ee.2019.15.2.83 · Cited by 145
“Low SHBG can be the result of insulin resistance.(47)”
BackgroundXing, C., Zhang, J., Zhao, H., & He, B. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s344542 · Cited by 118
“SHBG inhibits inflammation and lipid accumulation in macrophages and adipocytes, which may be a potential mechanism underlying the protective effects of SHBG in reducing the incidence of metabolic syndrome and its complications.(59)”
BackgroundBourebaba, N., Ngo, T., Śmieszek, A., Bourebaba, L., & Marycz, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113261 · Cited by 86
Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin
Song, M. J., & Choi, J. Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053709 · Cited by 74
“Furthermore, SHBG has anti-inflammatory and lipolytic effects on adipocytes and macrophages, which could explain its association with lower incidence rates of metabolic syndrome and its complications (100).”
Background
Metadata
- Authors
- Yamazaki, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Yamamotoya, T., Nakatsu, Y., Kikuchi, T., Kaneko, S., Tanaka, H., & Asano, T.
- Affiliations
- IMSUT Hospital (JP)
- The Institute of Medical Science, Asahi Life Foundation (JP)
- University of Miyazaki (JP)
- Nihon University (JP)
- Hiroshima University (JP)
- University of Tokyo Hospital (JP)
- Corresponding author
- Asano, Tomoichiro
- ORCID
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2018-06-25
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC6036814
- OpenAlex
- W2810907329
- Cited by
- 86
- References
- 60
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 9 · 2020: 7 · 2019: 5
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Institute for Adult Diseases Asahi Life Foundation (JP17K16158)
- Japan Society for the Promotion of Science (JP17K16158)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- sex hormone-binding globulin, metabolic syndrome, adipocytes, macrophages, inflammation, lipolysis, lipopolysaccharide, inflammatory cytokines, MCP-1, TNF-α, interleukin-6, JNK phosphorylation, ERK1/2 phosphorylation, 3T3-L1 adipocytes, testosterone, estradiol, lipid metabolism
- MeSH terms
- Animals, Anti-Inflammatory Agents, Estradiol, Humans, Inflammation, Lipolysis, Macrophages, Phosphorylation, Sex Hormone-Binding Globulin, Tumor Necrosis Factor-alpha, Interleukin-6, Adipocytes, Metabolic Syndrome, 3T3-L1 Cells, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages. https://app.cochat.ai/papers/10.1155/2018/3062319
- The paper
- Yamazaki, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Yamamotoya, T., Nakatsu, Y., Kikuchi, T., Kaneko, S., Tanaka, H., & Asano, T. (2018). Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome: In Vitro Evidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages. Mediators of Inflammation. https://doi.org/10.1155/2018/3062319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.